Department of Orthopedic Surgery, VieCuri Medical Centre, Venlo, The Netherlands; Department of Orthopedics and Research School Caphri, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Department of Orthopedic Surgery, VieCuri Medical Centre, Venlo, The Netherlands; Department of Orthopedics and Research School Caphri, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Vaccine. 2023 Sep 22;41(41):6042-6047. doi: 10.1016/j.vaccine.2023.08.043. Epub 2023 Aug 25.
Shoulder Injury Related to Vaccine Administration (SIRVA) is a rare disorder characterized by persistent shoulder pain and limited range of motion presenting within 48 h after vaccine administration. With the widespread distribution of the COVID-19 vaccine, the incidence of SIRVA is expected to rise. This sudden rise in vaccine administration presents an ideal opportunity to estimate the prevalence of SIRVA and to better characterize SIRVA.
This study aims to investigate the prevalence of SIRVA following COVID-19 vaccine administration among hospital workers in the Netherlands.
A questionnaire was sent to all hospital workers from a single non-academic hospital in the Netherlands. Respondents who had active SIRVA complaints were invited for an outpatient orthopaedic clinic assessment. Data was collected on participant characteristics and physical examination including assessment of active and passive range of motion (ROM). An ultrasound was performed to identify potential abnormalities.
32 out of 981 (3.3%) respondents reported shoulder pain with limited ROM occurring within 48 h after vaccine administration lasting for at least 7 days. Of these 32 respondents with SIRVA, 18 (56.2%) still reported active symptoms at the time of the survey. Clinical examination of 13 (72.2%) respondents with active SIRVA complaints showed limited glenohumeral ROM, limitations in activities of daily living and injection site pain. Twelve out of thirteen (92.3%) respondents with active SIRVA complaints showed abnormalities of the soft-tissue of the shoulder on ultrasound. Physiotherapy was the most common treatment modality for persistent SIRVA complaints (38.9%).
The prevalence of SIRVA is estimated at 3% in the adult working population. Signs and symptoms of SIRVA are variable in severity, localization and timing. Soft-tissue abnormalities is the most common clinical sign. This study contributes to clinician's knowledge on SIRVA, aiding in early recognition and treatment, which are imperative for prevention of persistent and severe shoulder pathology.
疫苗接种相关肩伤（SIRVA）是一种罕见的疾病，其特征是在疫苗接种后 48 小时内出现持续的肩部疼痛和运动范围受限。随着 COVID-19 疫苗的广泛分发，预计 SIRVA 的发病率将会上升。这种疫苗接种的突然增加为评估 SIRVA 的患病率并更好地描述 SIRVA 提供了理想的机会。
本研究旨在调查荷兰医院工作人员接种 COVID-19 疫苗后 SIRVA 的患病率。
向荷兰一家非学术性医院的所有医院工作人员发送了一份问卷。对有活动性 SIRVA 投诉的受访者邀请进行门诊矫形诊所评估。收集参与者特征和体格检查的数据，包括主动和被动活动范围（ROM）的评估。进行超声检查以识别潜在的异常。
981 名受访者中有 32 名（3.3%）报告称，在疫苗接种后 48 小时内出现肩部疼痛和受限的 ROM，持续至少 7 天。在这 32 名有 SIRVA 的受访者中，有 18 名（56.2%）在调查时仍有活动性症状。对 13 名（72.2%）有活动性 SIRVA 投诉的受访者进行临床检查，发现盂肱关节 ROM 受限、日常生活活动受限和注射部位疼痛。在 13 名（92.3%）有活动性 SIRVA 投诉的受访者中，有 12 名的肩部软组织在超声上显示异常。对于持续性 SIRVA 投诉，最常见的治疗方式是物理治疗（38.9%）。
SIRVA 的患病率估计在成年工作人群中为 3%。SIRVA 的体征和症状的严重程度、定位和时间各不相同。软组织异常是最常见的临床体征。本研究有助于临床医生了解 SIRVA，从而有助于早期识别和治疗，这对于预防持续性和严重的肩部病变至关重要。
